Today's NYSE & NASDAQ Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
ABNB Airbnb	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tom White Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$189.43	$175.00 ➝ $220.00	Buy
ADSK Autodesk	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Blair Abernethy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$260.66	$330.00	Buy
AFRM Affirm	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Harshita Rawat Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$77.76		Outperform
AGCO AGCO	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mircea Dobre Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$113.44 +0.0%	$120.00 ➝ $150.00	Neutral ➝ Outperform
AHR American Healthcare REIT	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.65 +0.2%	$66.00	Overweight
AIRJ AirJoule Technologies	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sean Milligan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.56		Hold
AMBA Ambarella	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Cassidy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.63	$120.00	Buy
ANAB AnaptysBio	Reiterated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$56.28	$78.00	Outperform
ANDG Andersen Group	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Marcon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.97 +0.4%	$57.00 ➝ $64.00	Outperform
ANF Abercrombie & Fitch	Upgraded by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christine Dooley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$148.05 -0.2%	$162.00	Hold ➝ Buy
MILLIONAIRE MASTERCLASS INVITE: Altucher (Ad) James Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation. Watch James Altucher's free masterclass before September 25
AON AON	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Meredith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$355.94 +0.2%		Neutral
ATTO Attovia Therapeutics	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Judah Frommer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.70	$39.00	Overweight
AUGO Aura Minerals	Downgraded by	Santander Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$84.53		Outperform ➝ Neutral
BNTX BioNTech	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Newman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$102.07 0.0%	$142.00 ➝ $136.00	Buy
BPOP Popular	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Rabatin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$169.75	$214.00 ➝ $216.00	Buy
BRCC BRC	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.52 +0.9%	$2.50 ➝ $25.00	Buy
BRVE Braveheart Bio	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Olivia Brayer Saunders Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.44	$40.00	Overweight
BRVE Braveheart Bio	Initiated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Condulis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.44	$45.00	Buy
BRVE Braveheart Bio	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$27.44	$48.00	Buy
BRVE Braveheart Bio	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$27.44	$48.00	Buy
BRVE Braveheart Bio	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$27.44		Buy
BW Babcock	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sean Milligan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.14 -0.3%	$20.00	Buy
BWAY Brainsway	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.30	$17.00 ➝ $19.00	Buy
CNI Canadian National Railway	Reiterated by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kristina Ruggeri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$125.89 -0.1%		Hold
CRM Salesforce	Target Raised by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Bonner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$256.60 +0.2%	$290.00 ➝ $300.00	Buy
CRSP CRISPR Therapeutics	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Silvan Turkcan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$57.72	$80.00	Market Outperform
CRSP CRISPR Therapeutics	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Blum Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$57.72	$82.00	Buy
CVNA Carvana	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ronald Josey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$74.24 +0.3%		Market Outperform
CYTK Cytokinetics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.09	$140.00	Buy
DE Deere & Company	Upgraded by	Nomura Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$630.66 +0.1%		Buy
DE Deere & Company	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mircea Dobre Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$630.66 +0.1%	$640.00 ➝ $800.00	Neutral ➝ Outperform
DELL Dell Technologies	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wamsi Mohan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$455.22 -0.2%	$500.00 ➝ $505.00	Buy
DOC Healthpeak Properties	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.96	$24.00	Mixed
DVN Devon Energy	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Gruber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$47.42 +0.1%		Buy
EIX Edison International	Reiterated by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Crowdell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.09 -0.1%	$86.00 ➝ $70.00	Outperform ➝ Neutral
FISV Fiserv	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ramsey El-Assal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.18	$53.00	Neutral
FRO Frontline	Downgraded by	Nordea Equity Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$44.02 -0.4%		Hold
GANX Gain Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.77	$8.00	Buy
GNL Global Net Lease	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitch Germain Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.16	$10.00	Market Outperform
GTLB GitLab	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lucky Schreiner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.87	$35.00 ➝ $45.00	Neutral
Tomorrow morning's stock alert (Ad) Our research analysts are set to release their next stock idea tomorrow morning just before 12:00 PM Eastern. Don't miss your chance to be the first to see our next stock pick. Get The Early Bird's Stock of the Day (Free)
GTLB GitLab	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Ruykhaver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.87	$35.00 ➝ $50.00	Neutral
GTLB GitLab	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nick Altmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.87	$36.00 ➝ $52.00	Buy
GWRE Guidewire Software	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Vruwink Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$205.81 0.0%	$202.00 ➝ $235.00	Outperform
HPE Hewlett Packard Enterprise	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wamsi Mohan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$52.31	$80.00 ➝ $82.00	Buy
INFY Infosys	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$12.09 +0.3%		Hold
IONS Ionis Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.05	$115.00	Buy
JAN JAN	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.41 -0.3%	$34.00	Overweight
KALU Kaiser Aluminum	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Stansbury Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$156.38	$184.00	Neutral ➝ Buy
LITE Lumentum	Initiated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$895.00		Outperform
LITE Lumentum	Target Set by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$895.00	$1,100.00
MDB MongoDB	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Blakey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$446.62	$416.00 ➝ $540.00	Overweight
MNSO MINISO Group	Reiterated by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lina Yan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.33	$10.80	Buy ➝ Hold
MPLT Maplight Therapeutics	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ami Fadia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.60	$45.00 ➝ $43.00	Buy
MSFT Microsoft	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$513.53		Market Outperform
NET Cloudflare	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fatima Boolani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$299.69 -0.1%		Market Outperform
OHI Omega Healthcare Investors	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.96 -0.1%	$50.00
OHI Omega Healthcare Investors	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Haendel St. Juste Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.96 -0.1%	$45.00 ➝ $46.00	Neutral
PANW Palo Alto Networks	Reiterated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Levine Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$371.59		Outperform
PATH UiPath	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Radi Sultan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.21 +0.3%		Neutral
PCG Pacific Gas & Electric	Downgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Thalacker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.63 +0.2%		Outperform ➝ Market Perform
PCG Pacific Gas & Electric	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$16.63 +0.2%		Overweight ➝ Buy
PCG Pacific Gas & Electric	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Thalacker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.63 +0.2%	$28.00 ➝ $21.00	Outperform ➝ Market Perform
PCG Pacific Gas & Electric	Reiterated by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Crowdell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.63 +0.2%	$21.00 ➝ $16.00	Outperform ➝ Neutral
PHR Phreesia	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.17 +0.2%	$14.00	Buy
PINS Pinterest	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$23.20 +0.0%		Hold ➝ Buy
RMD ResMed	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Fishbin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$240.47 +0.1%	$255.00 ➝ $267.00	Overweight
RVMD Revolution Medicines	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ami Fadia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$207.88	$240.00 ➝ $275.00	Buy
SBRA Sabra Healthcare REIT	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Malhotra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.61	$20.00 ➝ $21.00	Neutral
SBRA Sabra Healthcare REIT	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.61	$23.00	Mixed
SCTX Scribe Therapeutics	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.44	$60.00	Buy
SNN Smith & Nephew SNATS	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.01 +0.1%		Neutral
SNOW Snowflake	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Blakey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$327.08 -0.3%	$282.00 ➝ $405.00	Overweight
SRE Sempra Energy	Reiterated by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Crowdell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$84.25 -0.1%	$104.00 ➝ $84.00	Outperform ➝ Neutral
STAG Stag Industrial	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Thillman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.19 +0.0%	$42.00	Neutral ➝ Outperform
TENX Tenax Therapeutics	Downgraded by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Seamus Fernandez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.13		Buy ➝ Neutral
TITN Titan Machinery	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mircea Dobre Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.86	$29.00
VIK Viking	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandt Montour Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$88.53 +0.0%	$90.00
VTR Ventas	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$91.78 0.0%	$102.00	Mixed
WAY Waystar	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Close Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.24	$30.00 ➝ $33.00	Buy
WELL Welltower	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$237.51 -0.2%	$259.00	Mixed
XP XP	Upgraded by	Itau BBA Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Pedro Leduc Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.66	$22.00	Market Perform ➝ Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 08:56 AM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NYSE and NASDAQ Stock Price Targets and Analyst Ratings

Frequently Asked Questions